Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments

Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments

Non-small cell lung cancer (NSCLC) is the most common lung cancer diagnosis, among which epidermal growth factor receptor (EGFR), Kirsten rat sarcoma (KRAS), and anaplastic lymphoma kinase (ALK) mutations are the common genetic drivers. Their relative tyrosine kinase inhibitors (TKIs) have shown a b...

Full description

Bibliographic Details
Main Authors: Shanshan Chen, Jingyi Tang, Fen Liu, Wei Li, Ting Yan, Dangang Shangguan, Nong Yang, Dehua Liao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
non-small cell lung cancer
driver mutation
tyrosine kinase inhibitor
tumor microenvironment
ICIs - immune checkpoint inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1094764/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1094764/full

Similar Items